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impact (eg HAQ 2.37, PI HAQ 4.125) while others with lower disability had
higher impact (eg HAQ 1.5, PI HAQ 4.25).
PI HAQ scores were significantly lower than baseline at weeks 2, 4, 6 and 8
(median changes: -0.63, -0.19, -0.5, -0.38, all p<0.04). Using the median %
change from baseline, improvements at weeks 2, 4, 6 and 8 were greater for
the impact of disability (PI HAQ 12.5%, 5.4%, 9.5%, 7.1%) than for disability
alone (HAQ 4.3%, 3.8%, 9.1%, 4.3%).
Overall median change in PI HAQ was associated with change in the im-
pact of disability as measured by the DRP function scale (r=0.399, p<0.05).
Change in PI HAQ was associated only with change in HAQ (r=0.606,
p<0.01) whereas change in DRP was associated with change in all symp-
toms.
A subset of 10 patients did not respond to i/m glucocorticoids (defined as
a median improvement of <10% in the majority of variables, excluding PI
HAQ). In the 26 patients who did respond, PI HAQ changes were more
marked: median change from baseline at weeks 2, 4, 6 and 8: -0.69, -0.5,
-0.63, -0.5, all p<0.013). Using the median % change from baseline, im-
provement in disability impact was greater for the responders at weeks 2, 4,
6 and 8 (PI HAQ 18.7%, 9.3%, 16.7%, 13.3%), which was also greater than
the improvement in disability (HAQ 7.7%, 11.1%, 12.5%, 7.1%).
Conclusions: The PI HAQ is sensitive to change in RA patients and associ-
ated with changes in another disability impact measure (DRP). The PI HAQ
provides a valid and useful measure of the impact disability in RA and sug-
gests that i/m glucocorticoids may change the impact of disability more than
they change disability.
References
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414. SENSITIVITY TO CHANGE OF THE
RHEUMATOID ARTHRITIS SELF-EFFICACY SCALE
(RASE)
S. Hewlett1, Z. Cockshott1, C. Almeida1, P. Richards1, R. Lowe2,
R. Greenwood3, J. Kirwan1, R. Study Group. 1Academic Rheumatology,
University of Bristol, Bristol, United Kingdom; 2Psychology, University of
Wales, Swansea, United Kingdom; 3Research and Development, Bristol
Royal Infirmary, Bristol, United Kingdom
Background: Patient self-management programmes in RA aim to improve
outcome by prompting the patient to adopt self-management behaviours.
Self-efficacy, or the belief that you can do a task, is believed to be a neces-
sary precursor to initiating behaviour change. This study tests the sensitivity
to change of a new scale to measure self-efficacy for self-management in
RA patients in the UK (RASE).1
Methods: RA patients at 11 centres, who had been offered an education/
self-management programme as part of routine clinical care, were invited
to complete questionnaires at baseline, and 2 and 8 weeks after their pro-
gramme. Programmes were not standardized as this was a pragmatic study
of the RASE in current practice.
Results: 140 patients participated (79.7% female, mean age 56.6 years
(SD 12), disease duration 5yrs (SD 8.6). Patients had moderate pain (mean
4.6/10, SD 2.8) and disability (HAQ 1.36/3, SD 0.71), little depression (HAD
5.7/21, SD 3.6), but moderate anxiety (7.26/21, SD 4.1) and helplessness
(AHI 17.2/35, SD 4.6). Baseline self-efficacy was relatively high as measured
by the RASE (106.8/140, SD 11.8) and General Self-Efficacy Scale (GSES
28.8, SD 5.7, scale 10-40), but moderate as measured by the Arthritis Self-
Efficacy Scales (ASES pain 55, SD 18.1; ASES other symptoms 58.1, SD
19.3, scale 10-100).
The RASE showed small but significant improvements in self-efficacy 2
weeks after programme end (mean change 3.23, SD 9.38, p<0.0001), main-
tained at 8 weeks (mean change 2.77, SD 10.25, p<0.003). These changes
gave effect sizes of 0.344 and 0.27 at 2 and 8 weeks. Changes in RASE were
associated with behaviour initiation at week 2 (r=0.419, p<0.001) and week
8 (r=0.342, p<0.001). RASE change was also associated with a reduction
in illness resignation at week 2 (r=0.228, P=0.012) but this effect was lost by
week 8 (Medical Coping Modes Questionnaire).
The ASES showed similar effect sizes (ES). ASES pain: wk 2 ES 0.33 (mean
change 5.97, SD 18.26), wk 8 ES 0.36 (mean change 6.31 SD 17.43); ASES
other symptoms, wk 2 ES 0.42 (mean change 5.96, SD 14.23), wk 8 ES 0.41
(mean change 6.36, SD 15.61). GSES showed smaller effect sizes: wk 2 ES
0.24 (mean change 1.31, SD 5.42), wk 8 ES 0.27 (mean change 1.52, SD
5.52).
Conclusions: The RASE is sensitive to change in a cohort of UK patients
receiving routine self-management programmes in normal care. Changes
are associated with behaviour initiation and a reduction in illness resignation.
References
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415. RHEUMATOLOGICAL EDUCATION FOR
UNDERGRADUATE NURSING, PHYSIOTHERAPY AND
OCCUPATIONAL THERAPY STUDENTS IN THE UK
C. Almeida1, S. Hewlett1, B. Clarke2, L. Kay3, S. Ryan4, A. Chadwick5,
A. Hammond6. 1Academic Rheumatology, University of Bristol, Bristol; ;
2Faculty of Nursing, University of West of England, Bristol;
3Musculo-Skeletal Unit, Freeman Hospital, Newcastle; 4Staffordshire
Rheumatology Centre, Haywood Hospital, Stoke on Trent; 5Physiotherapy
Studies, Keele University, Keele; 6Rheumatology Unit, Derbyshire Royal
Infirmary, Derby, United Kingdom
Background: Rheumatological conditions are common, thus nurses, phys-
iotherapists (PT) and occupational therapists (OT) require knowledge and
skills to assess and manage their impact on physical, psychological and so-
cial health.
This study examines rheumatological education of undergraduate nurses,
PTs and OTs in the UK.
Methods: Curriculum organizers and clinical placement organizers for every
undergraduate course in adult nursing, PT or OT in the UK were sent a
questionnaire on the rheumatological content of their courses.
Results: 47 adult nursing courses, 30 PT, and 26 OT courses are being
delivered in the UK. A curriculum questionnaire (teaching), clinical placement
questionnaire (experience) or both, were returned for 40 nursing courses, 27
PT and 22 OT courses (85%, 90%, 85%).
Teaching about rheumatoid arthritis (RA) was moderate/in depth in only 52%
of nursing courses (PT 96%, OT 91%) with probable/definite clinical ex-
posure in 56% (PT 88%, OT 72%). Nursing courses were weaker for OA
teaching (63%, PT 92%, OT 91%) and clinical experience (63%, PT 96%,
OT 83%). Pain management and patient education teaching and experience
were available for 78-100% of the professions (clinical experience for only
61-72% of OTs). Psycho-social issues were less frequently taught (nursing
61%, PT 77%, OT 77%) or covered clinically (nursing 61%, PT 67%, OT
56%).
Whilst 89-100% of respondents knew of local rheumatology services, only
57% of nursing respondents knew about local specialist nurses (90% of PT
respondents knew of local PTs, OT’s 87%). Use of local rheumatology practi-
tioners to help educate their own profession was limited for teaching (nursing
19%, PT 27%, OT 52%) but better for clinical experience (nursing 54%, PTs
83%, OTs 82%). Teaching across disciplines (eg PT exposure to nursing) oc-
curred in only 6-27% of disciplines, with only 8-42% given multi-disciplinary
clinical experience.
Rheumatological undergraduate education provision was deemed about
right by only 50% of nursing and 58% of PT respondents, but by 76% of
OT respondents.
Conclusions: Undergraduate nurses, PTs and OTs have limited education
in key rheumatological disorders and consequences, with limited use of spe-
cialist practitioners and cross-discipline exposure. Further work needs to
identify core knowledge and skills for the professions at graduation, and ways
to achieve them.
416. MEASURING PROTECTIVE SENSATION IN THE
FEET OF PATIENTS WITH RHEUMATOID ARTHRITIS
(RA)
O.S.L. Wilson1,2, J.R. Kirwan1. 1Academic Rheumatology Unit, University
of Bristol, Bristol, United Kingdom; 2Podiatry Department, Central Health
Clinic, Towerhill, Bristol, United Kingdom
Background: Several authors have reported the presence of sensory neu-
ropathy in the feet of patients with RA, but its incidence, prevalence and
clinical progression are unclear. Using electromyography or nerve conduc-
tion techniques to assess sensation in the feet is time consuming, difficult
and expensive. We therefore set out to validate of the use of sensitivity to
monofilaments pressed against the skin as a method of assessing sensation
in the feet of patients with rheumatoid arthritis (RA), to calculate initial es-
timates of prevalence of loss of sensation and to investigate its association
with disease status.
Methods: Clinical examination of the feet of 51 patients with RA and 20
normal controls. 6 sites on each foot were tested twice with both 10g and 3g
research grade monofilaments and this was repeated after 6 weeks. Disease
status was measured using DAS, HAQ, visual analogue scales of pain, and
the acute phase response using ESR and PV.
Results: Reproducibility was high for 3g (kappa = 0.73) and 10g (kappa
= 0.75) monofilaments. The best balance between sensitivity (58.8%) and
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specificity (92.3%) for distinguishing the feet of patients from the feet of con-
trols was using the 3g filament and defining reduced protective sensation as
being sensitive to less than 11 of 12 applications. Using this definition, the
prevalence of reduced protective sensation is 12.5% in the feet of controls.
There was some variation in sensation over 6 weeks in the patient group, but
this was not related to measures of clinical status.
Conclusions: The use of monofilaments in assessing sensation levels in
the RA foot is valid and reproducible, and requires only a short time to per-
form. The prevalence of reduced sensation in the feet of patients with RA
was greater than previously reported. Future studies should be powered to
assess relationships with disease duration and inflammatory status.
417. DISCRIMINATION OF THE NEUTRAL LOW BACK
SITTING POSTURE IN PEOPLE WITH AND WITHOUT LOW
BACK PAIN, BEFORE AND AFTER A SHIFT OF WORK
D.R. Phillips1, M.V. Hurley2, M.A. Mullee3. 1School of Health Professions &
Rehabilitation Sciences, University of Southampton, Southampton, United
Kingdom; 2Rehabilitation Research Unit, King’s College, London, United
Kingdom; 3Research & Development Support Unit, University of
Southampton, Southampton, United Kingdom
Background: The "neutral" lumbar posture is considered the position least
likely to cause low back pain, with errors as little as 2° from the neutral spinal
posture substantially decreasing the axial compressive load capacity of the
spine. Accurate sensory feedback from, and activation of, appropriate trunk
muscles is essential for appreciation and maintenance of the neutral spinal
posture. If these muscles are dysfunctional due to low back pain and/or work-
related activity and fatigue, this might impair people’s ability to discriminate
the neutral spinal posture. This study investigated whether LBP or a shift of
work alters people’s ability to discriminate the neutral low back sitting pos-
ture.
Methods: Sixty one subjects with, and forty subjects without, a history of
LBP were recruited. Each subject’s spinal position sense was assessed be-
fore and after a shift of work by an electro-goniometer placed over the lum-
bar sacral spine. Subjects were blindfolded and instructed to actively locate
the neutral low back sitting posture – the "test" position. They were then
asked to flex or extend their low back and stop at a random position for 3
seconds, before returning to the neutral low back sitting position; the posi-
tion they returned to was the "reproduced" position. This procedure was re-
peated 20 times in total. The absolute error between the "test" position and
each "reproduced" position was calculated in degrees. The average mean
error was then calculated and compared between the two groups using an
independent-samples t test.
Results: Data was not normally distributed and therefore log-transformed
before analysis. Anti-logged (returning data to original scale) values are also
presented. LBP subjects had slightly higher average mean error values be-
fore work, showing that they found it more difficult than NLBP subjects to
discriminate the neutral low back sitting posture, but the difference was non-
significant (Table 1).
Table 1. Error in low back position sense when returning to the "neutral" sitting posture.
Data presented in degrees as mean (SD)
LBP subjects NLBP subjects Mean difference (95% CI) P value
n=61 n=40
before work 4.83a 4.01a
1.58 (0.65)l 1.39 (0.56)l -0.19 (-0.44 to 0.06)l 0.137
after work 4.38a 4.36a
1.48 (0.67)l 1.47 (0.54)l -0.004 (-0.26 to 0.25)l 0.973
a
= geometric mean; l = natural-logs value
Conclusions: The ability of people with and without LBP to appreciate the
neutral low back sitting posture was similar, both before and after a shift of
work.
418. A PILOT STUDY TO DETERMINE THE
PREVELANCE OF ERECTILE DYSFUNCTION IN MEN
WITH RHEUMATOID ARTHRITIS
G. Grundy1, J.K. Dawson1, R.J. Moots2, S. Mpofu1. 1Academic
Rheumatology, University Hospital Aintree, Liverpool, United Kingdom;
2Rheumatology Practice Development Unit, St Helens and Knowsley
Hospitals NHS Trust, St Helens, United Kingdom
Background: Rheumatoid Arthritis (RA) is a chronic inflammatory joint dis-
ease associated with many extra-articular manifestations - all contributing
to a high prevalence of disability. Erectile Dysfunction (ED) is a multifaceted
problem caused by a combination of organic and/or psychological factors.
It’s true prevalence in the UK is not known. Despite recent developments in
treatment for ED, the associated social stigma leads to very few men seek-
ing medical help. Depression and cardiovascular disease are independently
linked to the development of ED and both are more common in patients with
RA.
Methods: Thirty male patients with a diagnosis of RA were recruited: 21
(67%) rheumatoid factor (RF) positive; mean age 58 yrs (range 39-79);
mean disease duration 10 years (range 0.5 years – 42 years). A demo-
graphic questionnaire was completed and the following clinical data col-
lected. Medical History, blood pressure, Body Mass Index (BMI), Disease
Activity Score (DAS), Health Assessment Questionnaire (HAQ), smoking his-
tory (pack years). Sexual Health Inventory for Men (SHIFM), (a score of >21
= ED). Centre for Epidemiologic Studies Depression Score (CES-D), (score
> 15 = depression). Visual Analogue Score for general health (VAS). Venous
blood was drawn for C-reactive protein (CRP), rheumatoid factor (RF), fast-
ing blood sugar (FBS), cholesterol, serum total testosterone, sex hormone
binding globulin (SBGH), follicle stimulating hormone (FSH), luteininzing hor-
mone (LH), testosterone free index (TFI). Bloods were all taken before 11am.
Results: Nine (30%) men had ED. There were significant correlations be-
tween ED and age (p=0.04) (t-test), depression (p=0.043) (Mann-Whitney),
HAQ(p=0.045)(M-W) and alcohol intake (p=0.018)(M-W). Ten (33%) had a
HAQ score between 0 and 1; 13 (43%) had a HAQ score >1 – 2, 7(23%)
had a HAQ score >2 – 3. Twelve (42%) had a depression score greater than
15 (p=0.01) (Chi square). Seven (23%) drank 21 or more units of alcohol
per week. When age was controlled for, depression (p=0.001) and diastolic
BP(p=0.001) correlated with ED. When both age and depression were con-
trolled for, ED correlated with LH (p=0.042)and FBS (p=0.037). We could not
establish links between other variables and ED.
Conclusions: These data show that ED is prevalent in men with RA. Since
the study excluded men with co-morbidities, such as diabetes or cardiovas-
cular disease, the data are even more striking - and close to the prevalence
of 50% in men with diabetes. Erectile dysfunction appears to be a significant
health issue in men with RA and merits further study, focusing on potential
mechansims and the results of therapeutic intervention.
419. AN ORIGINAL SPLINTING TECHNIQUE:
BESPOKE NEOPRENE SPLINTS WITH THERMOPLASTIC
SUPPORT
P. Renforth1, F. Birrell1,2,3. 1Rheumatology, Northumbria Healthcare NHS
Trust, Newcastle upon Tyne, Northumberland, United Kingdom;
2Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, Tyne &
Wear, United Kingdom; 3Musculoskeletal Research Group, University of
Newcastle upon Tyne, Newcastle upon Tyne, Tyne & Wear, United Kingdom
Background: NAROT’s (National Association of Rheumatology OTs) recent
splinting guidelines recommend orthoses as a modality for patients with in-
flammatory arthritis. Commercial functional wrist splints are empirically used
in clinical practice but there remains a paucity of controlled evidence to sup-
port their efficacy. Large numbers of these splints are worn incorrectly or
issued inappropriately.
We have developed a novel splint made from neoprene with external ther-
moplastic support directly applied; this method of customising splints has
potential advantages compared to ready made splints and we have there-
fore undertaken preliminary qualitative assessments.
Methods: Consecutive patients referred to the rheumatology service in
Northumberland between April 2003 and August 2003 were included. Fol-
lowing assessment, all patients were issued with both ready made, Futuro-
style, wrist splints and neoprene wrist splints customized to individual need.
Patient satisfaction, perceived effectiveness of neoprene splints and the pre-
ferred splint were elicited in an unstructured interview with the Occupational
Therapist. Cost estimates were made for the novel splint, compared to ready
made splints.
Results: 79 consecutive patients were seen. The diagnoses were: Rheuma-
toid Arthritis 71%; Psoriatic Arthritis 23%; Fibromyalgia 5%; Raynaud’s 1%.
More than 90% of patients expressed a preference for neoprene splints. Pa-
tient’s subjective responses were recorded: pain relief 68%; support 60%;
comfort 56%; heat benefit 27%; reduced swelling 10%; problems with neo-
prene 7%.
Feedback from patients was very positive. Patients were able to contribute to
the design and development of their own splints. The splints allowed greater
flexibility with support and conformity.
Cost: ready made splints can be expensive to buy particularly if ordered
through Orthotic companies e.g. up to £50 for the supply and fitting of one
splint. The total material cost of a neoprene splint with thermoplastic rein-
forcement on both radial and ulnar borders of the wrist and hand is less than
£1.50 but requires additional therapist time (estimated at 7-10 minutes per
splint this equates to a total splint cost of ∼£4).
Conclusions: The qualitative data does support the use of original bespoke
neoprene splints rather than ready made splints. Patient satisfaction was
considerable and patient preference overwhelming, supporting the use of
these splints.
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However, this was a pragmatic clinical study and the time, cost-effectiveness
and benefits to patients provided by using neoprene splints would be best
assessed in a controlled study.
420. THE PREVALENCE OF DISABLING FOOT PAIN
IN PATIENTS WITH RHEUMATOID ARTHRITIS
M. Lohkamp1, G. Burrow1, T. McCarron1, W. Maclaren2,
M. Granat1. 1School of Health and Social Care, Glasgow Caledonian
University, Glasgow; 2School of Computing and Mathematical Sciences,
Glasgow Caledonian University, Glasgow, United Kingdom
Background: Foot involvement is common in RA patients with pain being
reported early in the disease process. Foot pain can lead to impairment of
gait and disability and hence reduce quality of life. Data about the preva-
lence of foot pain and the degree of disability are essential to evaluate how
serious these problems are in the group of early diagnosed RA patients.
With this knowledge, a treatment strategy to prevent or ease foot pain can
be developed. Therefore the aim of this study was to gather data about the
prevalence of foot pain in early diagnosed RA patients and quantify its effect
on disability.
Methods: Ethical approval was granted and written informed consent was
given. Patients who were older than 16 years and diagnosed with RA up to
3 years prior to the survey were asked to complete a questionnaire which
included demographic questions and questions about the prevalence of foot
pain related to RA during the last month and at present. Participants with
foot pain also filled in the Manchester Foot Pain and Disability Questionnaire
(MFPDQ) which is a valid tool for quantifying disabling foot pain. It comprises
19 questions of 4 subscales with the following aspects: pain, ambulation,
personal appearance and social life.
Descriptive statistics of the data were obtained with Microsoft Excel.
Results: The prevalence questionnaire was completed by 163 patients with
a mean age of 52.2 years (16-84 years) and a mean disease duration of
20.3 months (1-36 months). Foot pain was reported in 64% of these patients
during the last month and 59% experienced pain at the time of completing
the questionnaire. 113 patients completed the MFPDQ and the results are
illustrated in Table 1.
Table 1. Results MFPDQ
Total score Aambulation subscale Pain subscale
No disability 0.0% 0.9% 0.9%
Mild disability 16.8% 14.1% 14.1%
Moderate disability 54.0% 41.6% 64.6%
Severe disability 29.2% 43.4% 20.4%
Conclusions: The survey found that around 60% of the sample had foot
problems. These results show that foot pain is a serious problem that may
occur early in the disease. The total and the pain score of the MFPDQ
demonstrate a similar distribution with the majority of the patients having
moderate disability, followed by severe and minor disability. The ambulation
subscale shows a different picture with the greatest percentage reporting
severe disability, followed by moderate disability and minor disability. These
results show the high impact of foot pain on the patient’s life and especially
ambulation. It can be concluded that due to the high prevalence and the
severity of foot pain in patients with RA there is a need for adequate treat-
ment of this specific problem.
421. WHAT PATIENTS WITH RHEUMATOID ARTHRITIS
REALLY WANT TO KNOW - AN ASSESSMENT USING
THE EDUCATIONAL NEEDS ASSESSMENT TOOL
J. Hill1, A. Tennant2, A. Adebajo3, C. Hale1. 1ACUMeN, University of
Leeds, Leeds, W Yorkshire, United Kingdom; 2Department of
Musculoskeletal Rehabilitation, University of Leeds, Leeds, W Yorkshire,
United Kingdom; 3Rheumatology Department, Barnsley District Hospital,
Barnsley, United Kingdom
Background: The Educational Needs Assessment Tool (ENAT) has been
developed to quickly assess the educational and information needs of pa-
tients with RA. Using 1-5 likert scales it takes a few minutes for patients to
complete and comprises 7 domains; managing pain, movement, feelings,
arthritis process, treatments, self help and support. It is reliable (test/retest
r=0.823: p<0.01) the Rasch analysis showed it to be robust, unidimensional
and free from Differential Item Functioning.
Methods: The ENAT was completed by an opportunity sample of 125 RA pa-
tients attending either an outpatient clinic, a one day unit or were in-patients.
They were asked to complete the ENAT anonymously, unaided and return it
to the researcher.
Results: The majority of the cohort 99 (79%) were female. Age range was
19 - 86 years (median 57), median disease duration 12 years (range 0.2 - 47)
and median age at leaving full time education was 16 years (range 14-19).
In the pain domain, knowing more about taking the best medication for them
was thought to be extremely important by 81 (65%) patients. The use of
acupuncture, ultrasound and hydrotherapy n=25 (20%) were thought least
important. In the movement domain 75 (60%) thought it extremely important
that they had more information about prevention of joint damage. Knowl-
edge of practical aids was least important in this category (n=10; 8%). There
was less consensus in the section on feelings, but 53 (42%) of the cohort
wanted more information regarding tiredness. In the disease process sec-
tion, 83 (66%) patients thought it extremely important to know more about
treatments for their arthritis. Regarding treatments received from health pro-
fessionals, 85 (68%) wanted more information about side effects from medi-
cations. The self treatments section showed 48 (38%) of the cohort felt that
it was extremely important that they had further information about how much
to exercise and in the final section about support from others, 48 (38%) felt
it extremely important that they knew how to get the best from their consul-
tations with their doctor or nurse.
Many patients commented on the ease of completion and pertinence of the
questions.
Conclusions: Many of this cohort of RA patients had had their disease
for many years, but they still had unmet informational needs. Most patients
lacked information about medications and side effects, exercise, fatigue and
how to to obtain the best from their consultation.
The ENAT is user friendly and enables health professionals to provide timely
and meaningful education and information that is pertinent to the patient.
422. OUTCOME IN LOW BACK PAIN: WHAT MATTERS
TO THE PATIENTS?
R. Mullis, E. Hay, M. Lewis. Primary Care Sciences Research
Centre, Keele University, Newcastle under Lyme, Staffordshire, United
Kingdom
Background: The ability of patients with low back pain to perform "usual"
activities is frequently used as an outcome measure. "Usual" activity is a
multi-dimensional concept, varies greatly between individuals and is poorly
defined. We investigated the clinical usefulness of self reported ability to
perform "usual" tasks as a patient centred outcome measure in low back
pain. We explored the inter-relationship between this and a single individu-
alised question relating to the ability to perform a specific usually enjoyed
activity, self reported overall improvement in condition and general health
status.
Methods: This was a secondary analysis of data recorded at baseline and
12 months from a randomised clinical trial comparing two physiotherapy in-
terventions for low back pain (n=405) (Rheumatology 2004;43:ii86). At base-
line, participants responded to the Euroqol "usual activities" item; were asked
to identify a single activity that they enjoyed doing but were unable to do be-
cause of back pain and to rate the personal importance of this activity on a
10cm VAS. At 12 months participants were asked "Are you now able to do
this activity?". General health status was self-rated from "excellent" to "poor"
and overall improvement in condition from "completely recovered" to "much
worse" using modified Likert scales. Associations between ability to perform
"usual activities" and changes in these other outcomes were examined using
correlation and inferential analyses.
Results: At baseline, 142 patients stated that they had "no problem" with
usual activities but still identified a specific "enjoyed activity" they were pre-
vented from doing because of back pain. This subgroup rated the importance
of their enjoyed activity lower than patients who reported problems with usual
activities (p<0.001). At 12 months, patients who reported "no problem" with
usual activities were more likely to be able to perform their enjoyed activity
than those who still had problems (p<0.001).
Change in ability to perform "usual activities" was associated with change
in general health status (rho = 0.265, p<0.001) and overall improvement in
condition (rho = 0.243, p<0.001) at 12 months.
Those who could perform their enjoyed activity at 12 months rated their gen-
eral change in condition significantly better than those who were unable to
(p<0.001).
Conclusions: There are clear associations between patients’ responses to
"usual activities", and ability to perform a specific important enjoyed activ-
ity, general health status and global improvement in condition. However this
relationship is complex and depends on the degree of importance attached
to specific tasks. Responses to questions about "usual activity" may be less
meaningful than important task specific performance when assessing recov-
ery in a low back pain patient.
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423. MEASURING FATIGUE IN RHEUMATOID
ARTHRITIS: A SYSTEMATIC REVIEW OF THE SCALES
M. Hehir, S. Hewlett, J. Kirwan. Academic Rheumatology,
University of Bristol, Bristol, United Kingdom
Background: Fatigue has far-ranging consequences on the lives of patients
with RA and needs to be assessed accurately. The aim of this study was to
identify fatigue measures currently used in RA and examine their validity.
Methods: Scales in current use were identified by systematically searching
Medline, EMBASE, CINHAL, Psycho INFO, AMED, for papers containing the
terms "rheumatoid arthritis", plus "fatigue" plus each of the following terms in
turn: "scale" "questionnaire" "inventory" and "checklist". The searches were
repeated substituting "tiredness" for "fatigue". The abstracts of the papers
identified, were reviewed by two researchers and those reporting RA fatigue
data seperately from other data were retained, and the full papers obtained.
The fatigue scales used in these "index" papers were identified and the scale
validation papers obtained. Scale validation papers were reviewed systemat-
ically by three researchers for evidence of content and face validity (compre-
hensiveness and credibility); criterion and construct validity (accuracy and
biological sense); discriminant validity (sensitivity to change) and other ele-
ments of the OMERACT filter (truth, discrimination and feasibility).
Results: Of the 166 papers identified, 60 fulfilled the entry criteria of report-
ing RA fatigue separately. These 60 index papers used 19 different fatigue
scales in RA: NIH (activity record) ACTRE, Composite Index Fatigue Impair-
ment, Fatigue hours, Psychasthenia scale, Rating scale, Feeling tone check-
list, Time to onset of fatigue, Morning fatigue, Multidimensional fatigue inven-
tory, Chalder Fatigue Scale, Nottingham Health Profile, Checklist Individual
Strengths, Profile of Mood States, 5 items modelled after Tack, Chronic Fa-
tigue Index, Multidimensional Aspects of Fatigue, SF 36, Visual analogue
scale, Likert Scale.
60 index papers used scales on 70 occasions but only 34 referenced them.
30/60 index papers used a VAS, 7 referenced it, and none actually related to
validation of VAS for measuring fatigue in RA. Of the 30 index papers using
a VAS, only 12 described them fully, and those 12 described 11 different
versions. 10/19 scales had only the index paper as a validation scource.
Using the agreed validation criteria, the first 8 of the 19 scales identified
above did not achieve adequate validation for measuring fatigue in RA. The
remaining 11 scales vary in the level of evidence of their validity.
Conclusions: Systematic analysis to identify the validity of scales used to
measure RA fatigue has proved difficult and time-consuming. Despite the
importance of accurate measurement, researchers often create new and
unvalidated scales, or use existing unvalidated scales, or do not quote the
validation papers.
424. A PRELIMINARY SURVEY
OF PATIENTS’ VIEWS IN RELATION TO THE USE OF
SUBCUTANEOUS METHOTREXATE IN THE MANAGEMENT
OF INFLAMMATORY ARTHRITIS
C.H. Marsden. Rheumatology, Mid Yorkshire NHS Trust, Wakefield, West
Yorkshire, United Kingdom
Background: Methotrexate (MTX) is an antimetabolite, Disease Modifying
Anti-Rheumatic Drug, which is widely used in the management of inflamma-
tory arthropathies.
Parenteral administration of the drug is increasing in popularity due to the
development of innovative service developments, which facilitate patients to
self-administer MTX at home.
Current studies have examined the bioavailability and safety of the drug in
parenteral form and patient satisfaction with the self-administration proce-
dure.
This study examines the patients’ lived experience of Parenteral MTX in rela-
tion to tolerability and efficacy in comparison to prior experience of the drug
in tablet form.
Methods: The entire accessible population of a nurse-led service to facili-
tate patient self-administration of parenteral MTX was included in a patient
survey. A self-administered questionnaire was given to a total of 58 patients
within the clinic setting. Initially 45 (77.5%) questionnaires were returned,
followed by a further 7 following a reminder letter. Therefore 52 (89.75%,
women 67.3% n=35, men 32.7% n=17) of the total number of questionnaires
were returned, and were included in the study. The age range of the sample
was 30-79 years, length of disease 1-20yrs+.
The data collected was primarily quantitative although participants were en-
couraged to comment about side effects experienced yet not specified in the
questionnaire and/or experience of MTX in general. Qualitative analysis of
these comments was therefore also undertaken.
The questionnaire covered three main themes:-
1. The patients experience of oral MTX.
2. Side effects experienced with both routes of administration, including a
comparison of severity since changing to injections.
3. The patients’ experience of parenteral MTX, including impressions of tol-
erability and efficacy.
Results: The mean number of individual side effects experienced on oral
MTX was found to be 3.7 (st dev. 2.57) and 2.5 (st dev.2.01) with parenteral
MTX (P=.001, two-tailed significance, Wilcoxen Test). A one sample t-test
was indicated the probability of patients experiencing an improvement in
the severity of side effects following conversion to parenteral administration.
Mean 3.4 (st dev. 5.9, 95% conf. int. of 1.78 - 5.1, P=.001). 67.3% partici-
pants reported being able to tolerate higher doses of MTX in parenteral form.
46.8% of participants reported "much better" disease control, and 34.6%
"slightly better" control with parenteral MTX, with no negative responses.
Conclusions: Patients are likely to experience fewer and/or less severe side
effects with parenteral MTX, allowing them to tolerate higher doses, which
may lead to improved disease control.
Limitations of the study and implications for future practice and research are
discussed.
425. WHY DO PATIENTS WITH RHEUMATOID
ARTHRITIS USE COMPLEMENTARY THERAPIES?
G. Rose. Rheumatology Department, Ipswich Hospital
NHS Trust, Ipswich, Suffolk, United Kingdom
Background: It is becomming increasingly apparent that patients with
Rheumatoid Arthritis are turning to forms of Complementary Therapy (CT)
to supplement prescribed medication. The aim of this study is to (a) develop
an understanding as to how the use of CT affects a patients perspective
of health and well being, (b) to offer the rheumatology professional insight
and understanding as to why a patient chooses to use a CT, and (c) to
raise awareness as to the forms of CT most commonly used by patients
with Rheumatoid Arthritis.
Methods: This qualitative study was based on phenomenological principles
applied through focused inquiry to develop an understanding of the lived
experience of the study participants. An inclusion criteria of an established
diagnosis of Rheumatoid Arthritis, and known use of CT was applied to a
convenience sample of patients attending Rheumatolgy Outpatient Depart-
ment clinic on two consecutive days. Of the 15 eligible patients identified,
5 were randomly selected for inclusion in the study. Narrative data was col-
lected through analysis of transcripts taken from audio tape recordings of
unstructured interviews with study participants. A manual indexing system
was used to develop 4 significant categorisation themes to reflect the find-
ings (1) incentives to use CT, (2) perceived benefits of CT use, (3) the choice
of CT used, and (4) perceived disadvantages and risks of CT use.
Results: Incentives to use CT included dissatisfaction with conventional
treatment, often in the form of side effects and drug ineffectiveness. Social
factors such as loss of employment and social activities were also indicated,
as were psychological changes in the form of depression, hoplessness and
fear. Perceived benefits were categorised as either physical or psycholog-
ical with associated aspects of choice and control viewed as important el-
ements of personal empowerment. The choice of CT used fell into 3 cat-
egories; physical, spiritual and herbal. The most commonly used of these
were herbal remedies and supplements, closely followed by aromatherapy
massage. Disadvantages and risks were identified as physical, (pain and
discomfort), psychological (fear and uncertainty), and/or material (cost).
Conclusions: This study suggests that regular use of CT by patients with
Rheumatoid Arthritis offers holistic benefits. Compared to conventional treat-
ments, CT is seen to have advantages in terms of a lower incidence of
adverse reactions, greater patient choice, psychological comfort and an in-
creased quality of the patient/therapist realtionship. The evident use of CT
by patients with Rheumatoid Arthritis indicates a need for evidence based
information about its use and safety in order to direct practice within the
Rheumatology Department.
426. PEER AND PATIENT PERSPECTIVES OF THE
ROLE OF THE NURSE CONSULTANT IN
RHEUMATOLOGY
C. Thwaites, S. Ryan, A. Hassell, D. Home. School of Nursing and
Midwifery, Keele University, Keele, Staffs, United Kingdom; Department of
Rheumatology, Staffordshire Rheumatology Centre, Haywood Hospital,
Stoke-on-Trent, Staffs, United Kingdom; Department of Rheumatology,
Staffordshire Rheumatology Centre, Haywood Hospital, Stoke-on-Trent,
Staffs, United Kingdom; Dept of Rheumatology, West Middlesex University
Hospital NHS Trust, London, United Kingdom
Background: The nurse consultant role was introduced in 1998 to expand
the clinical career pathway and retain experienced nurses in clinical care.
Role criteria include expert clinical practice, developing education and re-
search initiatives and redefining services to improve patient outcome. We
wished to explore the perceptions and experiences of peers and patients of
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the role of the first Rheumatology nurse consultant appointed in the UK. This
study contributes to a Royal College of Nursing (RCN) project exploring the
effectiveness and impact of the nurse consultant.
Methods: A purposive sample of 6 peers (2 rheumatologists, 2 nurses, 1
manager and 1 consultant therapist) and 5 patients (attending the nurse con-
sultant rheumatoid arthritis review clinic) participated in a semi-structured
qualitative interview. A major aim of the interviews was to explore percep-
tions of the role of the nurse consultant. Interviews were conducted by a
nurse researcher (CT) not involved with the patients’ clinical care. The in-
terviews were tape-recorded, transcribed verbatim and analysed using Co-
laizzis procedural steps. The analysis was peer reviewed to ensure that the
results reflected the data.
Results: Four main functions of the nurse consultant emerged from the peer
interviews:
1. Developing a new chronic pain service
2. Enabling colleagues to reach their potential
3. Providing clinical education
4. Participation in research
Patients focused on (i) their sense of being looked after, (ii) the consultant
nurse’s empathy and (iii) the consultant nurse’s appreciation of the impact
of their condition. Peers also commented on the patient-centredness of this
nurse consultant. It is not clear whether these qualities are a virtue of the
individual or a feature of the role.
Conclusions: The use of qualitative interviews has enabled perceptions of
the role of the Rheumatology nurse consultant to be explored. The four key
activities which emerged from the peer interviews were found to relate to the
national criteria on role function. Patient perceptions of the role focused on
personal attributes and suggest that the nurse consultant is impacting pos-
itively on the patient experience. Further exploration of the views of health
professionals and patients on the role of the nurse consultant should con-
tribute to our understanding of its impact.
427. A RANDOMISED CONTROLLED PILOT STUDY OF
INFLAMMATORY ARTHRITIS PATIENTS ATTENDING
AN INDIVIDUAL OR A GROUP SESSION FOR
INFORMATION ON ANTI-RHEUMATIC DRUGS: COMPARING
DIFFERENCES IN CONCORDANCE WITH TREATMENT, PATIENT
SATISFACTION, TIME TAKEN AND DRUG SURVIVAL
D. Homer, P. Nightingale, P. Jobanputra. Rheumatology, UHB NHS Trust,
Birmingham, United Kingdom; Wolfson Centre, UHB NHS Trust,
Birmingham, United Kingdom; Rheumatology, UHB NHS Trust,
Birmingham, United Kingdom
Background: Providing information on anti rheumatic drugs usually takes
place with the patient and rheumatology nurse. There is no evidence com-
paring methods of providing drug information which is of importance be-
cause the drugs are toxic, require monitoring, and concordance improves
outcome. On this background a pragmatic randomised controlled pilot study
was conducted to compare drug information provided to individuals versus
groups of patients.
Methods: 62 patients with inflammatory arthritis, requiring information on
anti-rheumatic drugs received an individual or group drug information ses-
sion. A rheumatology nurse specialist saw all subjects using the same
drug specific leaflet. Outcomes were concordance by patient self report, pill
counts and record of attendance for blood tests and follow up appointments
for 12 weeks; Satisfaction 3 weeks post intervention using the Satisfaction
with Information about Medicines Scale (SIMS) and time taken to deliver
drug information and drug survival at 4 months.
Results: The EG subjects were more concordant than the CG, but not sig-
nificant statistically. There were no differences between the 10 groups.
Concordance Results, by pill count, attendance for follow up and blood monitoring
Concordance outcomes Group (EG) N=30 Individual (CG) N=32 Probability
Pill counts 90% 71% p = 0.11
Follow up attendance 97% 81% p = 0.10
Attend for blood monitoring 83% 75% p = 0.54
Satisfaction and drug survival was high overall.
Satisfaction, time taken and drug survival
Group (EG) Individual (CG) Probability Association
Satisfaction (SIMS) 15 (range 7-17) 16 (11-17) p = 0.3 no association
p = 0.07
Time taken 35 minutes 33 minutes p = 0.53
(range 25-45) (range 18-51)
Drug survival at 4 months 73% 62% p = 0.42
Time taken was equivocal but the actual amount of nurse time taken with the
EG’s was a mean of 11.6 minutes per subject compared to 33 minutes for
CG subjects.
Conclusions: This study has practice implications for optimal use of re-
sources and improving patient outcome. It is recommended that a larger
study be conducted with an exploration of the qualitative aspects of provid-
ing drug information.
This research was supported by an education grant to undertake the post
graduate diploma/Msc in rheumatology nursing at Keele University.
428. PARTICIPATING IN CLINICAL TRIALS: PATIENTS’
EXPERIENCES OF THE INFORMED CONSENT
PROCESS. A LITERATURE REVIEW
S.L. Grieve. Clinical Trials Unit, Bath Institute for Rheumatic Diseases, Bath,
United Kingdom; Royal National Hospital for Rheumatic Diseases, Bath,
United Kingdom
Background: As a rheumatology clinical research nurse, I am aware of the
importance of obtaining genuine informed consent. This literature review fo-
cuses on three research questions specifically relating to patient understand-
ing, randomisation and voluntariness.
Methods: The literature search was undertaken systematically using well
recognised databases, including MEDLINE and CINAHL. Explicit and clearly
defined methods1 were used to achieve a thorough and rigorous appraisal of
the best quality evidence. To further promote rigor and validity of the critical
appraisal, a research appraisal checklist was used, supporting the strengths
and limitations of the research papers. By careful selection of search terms
and clear inclusion criteria, the search strategy identified research papers
that could be used as best evidence to answer the research questions. Five
quantitative and three qualitative studies were selected.
Results: The appraised research showed that even when presented with an
easy to read consent form, patients were not identifying risks of participat-
ing and there was an unrealistic perception of benefit. The studies illustrated
that individuals can find randomisation difficult to understand as it often con-
flicts with their trial experience and preconceived ideas and beliefs may take
precedent. There is evidence of implicit trust in the clinician and difficulty ac-
cepting clinical equipoise. The findings identify that both comprehension and
patient autonomy increase with the presence of a research nurse or similar
health care professional, possibly because the patient sees this person as
being distanced from the therapeutic relationship.
Conclusions: Enabling an individual to make a truly informed consent is dif-
ficult to achieve in practice. Development of an information leaflet specifically
relating to randomisation may facilitate understanding. In practice it would be
advantageous for a research nurse to make the initial approach and seek the
decision from the patient. This may result in some of the influencing factors
relating to the voluntariness of consent, being reduced.
Reference
[1] Hek et al (2004) Making Sense of Research. An Introduction for Health
and Social Care Practioners.
429. WALKING THE LINE: EXPECTATIONS AND
INTENTIONS IN QUALITATIVE RESEARCH
INTERVIEWS IN RHEUMATOLOGY
E.D. Hale1, G.J. Treharne1,2 , D.L. Mitton1,3, S. Mole1, Y. Norton4,
C. Gordhan5, P.A. Bacon5, G.D. Kitas1,2,5. 1Department of Rheumatology,
Dudley Group of Hospitals NHS Trust, Dudley, West Midlands, United
Kingdom; 2School of Psychology, University of Birmingham, Birmingham,
United Kingdom; 3School of Health Sciences, University of Birmingham,
Birmingham, United Kingdom; 4West Midlands Branch, Lupus UK, Coseley,
West Midlands, United Kingdom; 5Department of Rheumatology, Division of
Immunology and Infection, School of Medicine, University of Birmingham,
Birmingham, United Kingdom
Background: Reflexive practice is an important part of the research pro-
cess, and particularly in qualitative work. Qualitative research interviews are
an effective tool for exploring lived experience in the rheumatic diseases. Our
intention was to deconstruct the qualitative interview process and examine
some of the difficulties encountered during a recent research project.
Methods: Semi-structured interviews were conducted with 14 women aged
26-77 with a range of rheumatic diseases. These were audio-recorded, tran-
scribed verbatim and analysed using Interpretative Phenomenological Anal-
ysis.
Results: Qualitative research interviews require not only a structure within
which to investigate the topic(s) of interest, but many of the skills and tech-
niques exercised by our colleagues in the counselling therapies in order to
facilitate the interview. These include listening skills; empathy; congruence;
positive regard; focusing and summarising. The ethical responsibilities of re-
searchers are paramount throughout the research process. Researcher in-
tentions and subsequently participant expectations should be clear from the
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beginning of the process, so that boundaries can be drawn and informed
consent given. Despite this, during research interviews, the nature of the
interview often makes a subtle shift from research interview to therapeutic
interview, as participants reveal previously undisclosed issues. However, the
research interview should not become a therapeutic counselling session as
a) it is unlikely the researcher has those skills b) it violates the boundaries
agreed in informed consent c) both researcher and participant may become
distressed and unsure how to proceed thereafter, as counselling rarely takes
the form of a single session.
Conclusions: We are concerned that there is a fine line to be walked during
the qualitative research interview for which qualitative interviewers may be
unprepared. Researchers should be aware that participant needs and ex-
pectations may shift during the course of the interview as they reveal their
narrative. Adopting the skills of the counsellor are entirely ethical and desire-
able and facilitate the inteview process, to such an extent that the interview
can be perceived as therapeutic in itself.
430. PATIENT PERCEPTIONS OF EMPOWERMENT/
SELF ACTUALISATION WHEN TAKING PART IN A
PARENTERAL METHOTREXATE SELF-ADMINISTRATION
PROGRAMME
J.M. White, C.A. Hale. Rheumatology Department, Leeds Teaching
Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom; School of
Healthcare Studies, University of Leeds, Leeds, West Yorkshire, United
Kingdom; ACUMeN, University of Leeds, Leeds, West Yorkshire, United
Kingdom
Background: In 2002 a parenteral methotrexate self-administration pro-
gramme was established in partnership with an external company within the
rheumatology department of the Leeds Teaching Hospitals NHS Trust.
The service was set up for the following reasons:
1. Patient/carer dissatisfaction at having to attend the hospital weekly for
therapy to be administered by rheumatology clinical nurse specialists.
2. Increasing numbers of patients requiring parenteral methotrexate.
3. Increasing strain on existing nursing and pharmacy resources.
In 2003 a survey was carried out to determine if a homecare methotrex-
ate self-administration programme was a worthwhile service to provide for
rheumatology patients. Part of this survey exained the subject of patient
empowerment/self-actualisation in detail.
Methods: A questionnaire was designed using five-point Likert Scales to
measure patients attitudes towards taking part in a parenteral methotrexate
self-administration programme.
The study was approved by the Local Research Ethics Committee (LREC).
A pilot study was carried out to test for reliability and validity of the question-
naire. Entry criteria was all patients who were participating in the homecare
programme at the time of the study (n=117). All patients had rheumatoid
arthritis.
Results were returned to a third party administrator to ensure patient confi-
dentiality.
Results: Overall response rate 79.5%.
Results were analysed using SPSS.
68.9% agreed that being able to give their own methotrexate made them feel
more confident.
64.4% agreed that giving their own methotrexate made them feel more in
control of their disease.
75.5% agreed that they felt they had really achieved something by learning
how to inject themselves.
91.1% agreed that they had been given a choice whether to administer their
own injections or not.
84.4% did not feel they had been left alone to cope.
83.3% did not feel isolated form the department by choosing to give their
own injections.
Conclusions: 1. Patients giving their own methorexate felt more confident
overall.
2. Giving their own injections made them feel more in control of their disease.
3. Patients felt they had really achieved something by learning to inject them-
selves.
4.Patients felt they were given a choice whether or not to participate in the
homecare programe
5. Self-adminstering at home did not make them feel as if they had been left
alone to cope.
6. Self-adminstering at home did not make them feel isolated from he
rheumatology department.
431. AN INFORMATION GATEWAY FOR THE FOOT
IN RHEUMATIC DISEASES
A.E. Williams1,2, C.J. Nester2, A. Mainwaring3, M. Berry2.
1Directorate of Podiatry, University of Salford, Salford, Manchester; 2Centre
for Rehabilitation and Human Performance Research, University of Salford,
Salford, Manchester; 3Directorate of Podiatry, Salford Royal Hospitals NHS
Trust, Salford, Manchester, United Kingdom
Background: Foot involvement in rheumatic disease can result in severe
foot pain and reduced mobility. Studies have promoted the value of interven-
tions such as prescribed orthoses and specialist footwear in the manage-
ment of the rheumatoid foot (Woodburn et al 2002, Hodge 1999).
However, the scale of foot problems presenting for professional foot health
assessment and management in patients with rheumatic diseases in the NW
region is not known. Underlying this is the lack of an information infrastruc-
ture to support large scale audit and research into foot health and foot care.
The development of standardised guidelines for the referral, assessment and
management of the foot in rheumatic diseases has been achieved by the
North West Clinical Effectiveness group (Foot in Rheumatic Diseases). The
group suggest that there are several key elements to the assessment and
management of these patients. These elements are supported by evidence
where it is available or general consensus where it is not.
Our aim was to put in place the infrastructure to support an information gate-
way to enable the University of Salford to collate clinical data on foot health
and care in patients with rheumatic diseases from remote NHS sites across
the North West.
Methods: Existing foot health assessment forms were analysed and a fo-
cus group was formed to explore the aspects of foot health assessment and
agree the requirements for a standardised self carbonated form. Following
a pilot study of the form and some minor alterations, the form was used in
18 trusts in the NW region with the original form being kept in the patients
records and the anonymous carbonated copy sent to Salford University.
Results: Five assessment forms have been returned to date from each of
the participating NW trusts (total n=60). The forms were analysed for cor-
rectness and usability. The data has also been analysed in respect of the
types of foot health problems, their management and the clinical outcomes.
Conclusions: The information collected to date has demonstrated that the
foot health assessment form provides the practitioner with a standardised
and comprehensive approach to assessment of the patient and foot.The Uni-
versity of Salford is at the hub of a continuous information system, which has
the potential to greatly advance our understanding of the foot care delivered
to patients with rheumatic diseases.
The information system will provide research data for the purposes of clinical
trials, health service research and service planning and delivery. There is
further work exploring the potential of an electronic version.
432. THE MANAGEMENT OF PATIENTS WITH
RHEUMATOID ARTHRITIS: SPLINT AND ORTHOTIC
PROVISION – RESULTS OF A SUREY FROM EIGHT
PHYSIOTHERAPY DEPARTMENTS
F. Keogan1, N. Kennedy2. 1Physiotherapy Department, Beaumont Hospital,
Dublin, Ireland; 2Department of Physiotherapy, University of Limerick,
Limerick, Ireland
Background: As a chronic disease patients with rheumatoid arthritis present
a challenge to physiotherapists working in the area of rheumatology. The
majority of these patients have foot and hand disease and require orthotic
and hand splints. A survey of patients with RA will highlight the frequency of
splint and orthotic use among this patient group, information which will be of
use to physiotherapists working in this area.
Methods: Patients with RA attending eight physiotherapy departments in
Ireland over a six month period from April to October 2003 were informed
about the survey and invited to participate. Informed consent was obtained
from all particiapnts. The survey form recorded details relating to patient
management, splint and orthotic use, footwear and the use of aids and ap-
pliances. The Health Assessment Questionnaire (HAQ) was recorded for all
participants. Ethical approval was required by and granted for six of the par-
ticipating centres.
Results: 273 patients (n=199) female participated in the survey. The mean
HAQ score was 1.61 (sd 0.77), indicating moderate disability. Mean age was
59.8 years while mean disease duration was 13.8 years. Less than 50%
(38.6%, n = 105) of participants wore orthotics. Of these, 46.7% were cus-
tom made. 50% of participants wore splints of which 16% were resting, 45%
were active and 39% of particiapants had both. The majority of splints were
provided by an Occupational Therapist (93.5%) with 6.5% provided by a
physiotherapist. The results were further examined to investigate the pro-
file of participants with respect to gait aid provision and use of aids and
appliances. T -tests were used to analyse differences between participants
with and without gait aids and with or without aids and appliances with re-
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spect to age, ESR, disease duration and HAQ scores. Participants with gait
aids were significantly older (p=0.026), had significantly longer disease du-
ration (p=0.037), higher ESR (p=0.012) and higher HAQ scores (p=0.015).
Participants with aids and appliances had a significantly longer disease du-
ration (p=0.05), higher ESR (p=0.002) and higher HAQ scores (p=0.001)
than those without. However, a considerable proportion of participants with
moderate (43%) or severe (29%) disability had no aid or appliance.
Conclusions: Results indicate that participants using gait aids were sig-
nificantly older, had longer disease duration, higher ESR levels and higher
HAQ scores. Participants with aids and appliances had significantly longer
disease duration, higher ESR and HAQ scores than those without. It is note-
worthy that the majority of participants with no aids or appliances had mod-
erate or severe disability.
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